Lorazepam
Lorazepam is a prescription benzodiazepine medication available as oral tablets in strengths of 0.5 mg, 1 mg, and 2 mg. Manufactured by Leading Pharma, LLC, it is a controlled substance (Schedule CIV) used for treating anxiety and related conditions. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Lorazepam is a prescription benzodiazepine medication available as oral tablets in strengths of 0.5 mg, 1 mg, and 2 mg. Manufactured by Leading Pharma, LLC, it is a controlled substance (Schedule CIV) used for treating anxiety and related conditions. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lorazepam",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lorazepam — ANDA 071591 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071591"
}
]
|
| identifier | ANDA071591 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"health-care",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lorazepam |
